<DOC>
	<DOC>NCT02406209</DOC>
	<brief_summary>This is a randomized, multi-center, investigator masked, comparator controlled study. The purpose of this study is to determine the efficacy and safety of NS2 in patients with non-infectious acute anterior uveitis. Subjects will be randomized 1:1:1 to receive multiple doses of NS2 0.5%, NS2 0.5% and Pred Forte® 1%, or Pred Forte® 1%. Free aldehydes are thought to be related to inflammatory diseases such as uveitis. NS2, a small molecule aldehyde trap, may decrease inflammation by lowering aldehyde levels.</brief_summary>
	<brief_title>A Safety and Efficacy Study of NS2 in Patients With Anterior Uveitis</brief_title>
	<detailed_description />
	<mesh_term>Uveitis</mesh_term>
	<mesh_term>Uveitis, Anterior</mesh_term>
	<mesh_term>Iridocyclitis</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Noninfectious anterior uveitis Grade 1 Grade 3 anterior chamber cell count Subjects must have Intraocular pressure &lt;25 mmHg at baseline and may only administer a maximum of 1 topical medication to control Intraocular pressure in the study eye. Visual acuity ≥ 20/200 in the study eye Severe/serious ocular pathology Active intermediate or posterior uveitis. Previous anterior uveitis episode in the study eye within 4 weeks of Visit 1 Oral corticosteroids within 14 days of Visit 1 Intravitreal or subTenon corticosteroid treatment in the study eye within the past 6 months.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>uveitis</keyword>
	<keyword>acute uveitis</keyword>
	<keyword>anterior uveitis</keyword>
	<keyword>NS2</keyword>
	<keyword>Aldeyra</keyword>
	<keyword>prednisolone acetate</keyword>
</DOC>